Phase I safety and pharmacokinetic profile of an intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302). (Record no. 9294136)

MARC details
000 -LEADER
fixed length control field 01386 a2200373 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513125611.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199710s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0022-3565
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Glover, J M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19971017
245 00 - TITLE STATEMENT
Title Phase I safety and pharmacokinetic profile of an intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302).
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. The Journal of pharmacology and experimental therapeutics
Date of publication, distribution, etc. Sep 1997
300 ## - PHYSICAL DESCRIPTION
Extent 1173-80 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Double-Blind Method
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Intercellular Adhesion Molecule-1
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oligodeoxyribonucleotides, Antisense
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oligonucleotides, Antisense
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Phosphorothioate Oligonucleotides
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thionucleotides
General subdivision adverse effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Leeds, J M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mant, T G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Amin, D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kisner, D L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zuckerman, J E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Geary, R S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Levin, A A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Shanahan, W R
773 0# - HOST ITEM ENTRY
Title The Journal of pharmacology and experimental therapeutics
Related parts vol. 282
-- no. 3
-- p. 1173-80

No items available.